logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Fulltext. Prospective cohort Study of antioxidant vitamin supplement use and the risk of age-related maculopathy.

    Article - En anglais

    Fulltext.

    In a prospective cohort study, the authors examined whether self-selection for antioxidant vitamin supplement use affects the incidence of age-related maculopathy.

    The study population consisted of 21,120 US male physician participants in the Physicians'Health Study I who did not have a diagnosis of age-related maculopathy at baseline (1982).

    During an average of 12.5 person-years of follow-up, a total of 279 incident cases of age-related maculopathy with vision loss to 20/30 or worse were confirmed by medical record review.

    In multivariate analysis, as compared with nonusers of supplements, persons who used vitamin E supplements had a possible but nonsignificant 13% reduced risk of age-related maculopathy (relative risk=0.87,95 percent confidence interval (Cl) 0.53-1.43), while users of multivitamins had a possible but nonsignificant 10% reduced risk (relative risk=0.90,95% Cl 0.68-1.19).

    Users of vitamin C supplements had a relative risk of 1.03 (95% Cl 0.71-1.50).

    These observational data suggest that among persons who self-select for supplemental use of antioxidant vitamin C or E or multivitamins, large reductions in the risk of age-related maculopathy are unlikely.

    Randomized trial data are accumulating to enable reliable detection of the existence of more plausible small-to-moderate benefits of these agents alone and in combination on age-related maculopathy.

    Mots-clés Pascal : Maculopathie, Homme, Prévention, Evaluation, Incidence, Etude cohorte, Chimioprophylaxie, Vitamine E, Supplémentation, Antioxydant, Questionnaire, Etats Unis, Amérique du Nord, Amérique, Oeil pathologie

    Mots-clés Pascal anglais : Maculopathy, Human, Prevention, Evaluation, Incidence, Cohort study, Chemoprophylaxis, E-Vitamins, Supplementation, Antioxidant, Questionnaire, United States, North America, America, Eye disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0168556

    Code Inist : 002B09I. Création : 16/11/1999.